0001637761-23-000042.txt : 20230109 0001637761-23-000042.hdr.sgml : 20230109 20230109191956 ACCESSION NUMBER: 0001637761-23-000042 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230105 FILED AS OF DATE: 20230109 DATE AS OF CHANGE: 20230109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FEKETE MICHAEL CENTRAL INDEX KEY: 0001581383 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36905 FILM NUMBER: 23519414 MAIL ADDRESS: STREET 1: C/O SAGENT PHARMACEUTICALS, INC. STREET 2: 1901 NORTH ROSELLE ROAD, SUITE 700 CITY: SCHAUMBURG STATE: IL ZIP: 60195 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SeaSpine Holdings Corp CENTRAL INDEX KEY: 0001637761 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 473251758 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5770 ARMADA DRIVE CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: (760) 727-8399 MAIL ADDRESS: STREET 1: 5770 ARMADA DRIVE CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 wf-form4_167330998234225.xml FORM 4 X0306 4 2023-01-05 1 0001637761 SeaSpine Holdings Corp SPNE 0001581383 FEKETE MICHAEL C/O SEASPINE HOLDINGS CORPORATION 5770 ARMADA DRIVE CARLSBAD CA 92008 1 0 0 0 Common Stock 2023-01-05 4 D 0 111966 D 0 D Stock Option (right to buy) 15.68 2023-01-05 4 D 0 59910 D 2025-08-01 Common Stock 59910.0 0 D Stock Option (right to buy) 17.18 2023-01-05 4 D 0 5015 D 2026-01-01 Common Stock 5015.0 0 D Stock Option (right to buy) 9.99 2023-01-05 4 D 0 18096 D 2026-06-07 Common Stock 18096.0 0 D Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 46,611 Orthofix Medical Inc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger. The option vests as to 25% of the underlying shares on November 1, 2015 and the remaining 75% in three equal quarterly installments thereafter. This option was assumed by Orthofix in the merger and replaced with an option to purchase 24,940 shares of Orthofix at a price of $37.67 per share. The option vests as to 50% of the underlying shares on February 1, 2016 and as to 25% of the underlying shares on each of May 1, 2016 and August 1, 2016. This option was assumed by Orthofix in the merger and replaced with an option to purchase 2,087 shares of Orthofix at a price of $41.27 per share. The option vests in four equal installments on each of September 7, 2016, December 7, 2016, March 7, 2017 and June 7, 2017. This option was assumed by Orthofix in the merger and replaced with an option to purchase 7,533 shares of Orthofix at a price of $24.00 per share. /s/ Paul Benny, Attorney-in-Fact for Michael Fekete 2023-01-09